These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


468 related items for PubMed ID: 4033326

  • 1. High-grade malignancies of the parotid gland: effective use of planned combined surgery and irradiation.
    Matsuba HM, Thawley SE, Devineni VR, Levine LA, Smith PG.
    Laryngoscope; 1985 Sep; 95(9 Pt 1):1059-63. PubMed ID: 4033326
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Outcomes following parotidectomy for metastatic squamous cell carcinoma with microscopic residual disease: implications for facial nerve preservation.
    Iyer NG, Clark JR, Murali R, Gao K, O'Brien CJ.
    Head Neck; 2009 Jan; 31(1):21-7. PubMed ID: 18767180
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Postoperative irradiation in malignant tumors of submandibular gland.
    Dai D.
    Cancer Invest; 1999 Jan; 17(1):36-8. PubMed ID: 10999047
    [Abstract] [Full Text] [Related]

  • 7. Acinic cell carcinoma of the parotid gland: review and management.
    Spafford PD, Mintz DR, Hay J.
    J Otolaryngol; 1991 Aug; 20(4):262-6. PubMed ID: 1920580
    [Abstract] [Full Text] [Related]

  • 8. Treatment of carcinoma of the parotid gland: the results of a multicenter study.
    Tullio A, Marchetti C, Sesenna E, Brusati R, Cocchi R, Eusebi V.
    J Oral Maxillofac Surg; 2001 Mar; 59(3):263-70. PubMed ID: 11243607
    [Abstract] [Full Text] [Related]

  • 9. Treatment of maxillary sinus carcinoma: a comparison of the 1997 and 1977 American Joint Committee on cancer staging systems.
    Le QT, Fu KK, Kaplan M, Terris DJ, Fee WE, Goffinet DR.
    Cancer; 1999 Nov 01; 86(9):1700-11. PubMed ID: 10547542
    [Abstract] [Full Text] [Related]

  • 10. Clinical prognostic factors in malignant parotid gland tumors.
    Lima RA, Tavares MR, Dias FL, Kligerman J, Nascimento MF, Barbosa MM, Cernea CR, Soares JR, Santos IC, Salviano S.
    Otolaryngol Head Neck Surg; 2005 Nov 01; 133(5):702-8. PubMed ID: 16274796
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Management of nasopharyngeal salivary gland malignancy.
    Schramm VL, Imola MJ.
    Laryngoscope; 2001 Sep 01; 111(9):1533-44. PubMed ID: 11568602
    [Abstract] [Full Text] [Related]

  • 13. 125I seed implant brachytherapy-assisted surgery with preservation of the facial nerve for treatment of malignant parotid gland tumors.
    Zhang J, Zhang JG, Song TL, Zhen L, Zhang Y, Zhang KH, Yang ZH, Yu GY.
    Int J Oral Maxillofac Surg; 2008 Jun 01; 37(6):515-20. PubMed ID: 18508237
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Simultaneous integrated boost intensity-modulated radiotherapy for locally advanced head-and-neck squamous cell carcinomas: II--clinical results.
    Lauve A, Morris M, Schmidt-Ullrich R, Wu Q, Mohan R, Abayomi O, Buck D, Holdford D, Dawson K, Dinardo L, Reiter E.
    Int J Radiat Oncol Biol Phys; 2004 Oct 01; 60(2):374-87. PubMed ID: 15380569
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 24.